Latest News

Lattice Semiconductor (LSCC) has been in focus after its shares rose 3.6% following the Trump administration’s plan for a voluntary consortium targeting up to US$4 trillion for semiconductor supply chains and related projects. See our latest analysis for Lattice Semiconductor. That consortium news lands on top of strong recent trading, with a 90 day share price return of 32.21% and a 1 year total shareholder return of 70.28%, suggesting that momentum has been building. If this kind of...

BlackRock (BLK) is back in focus after a fresh wave of digital asset launches and partnerships, ranging from a staked ether ETF to deeper iCapital and Aladdin Wealth integration around alternative investments. See our latest analysis for BlackRock. Despite the flurry of digital asset launches and alternative investment partnerships, BlackRock’s recent momentum has cooled. The 30 day share price return is 8.37% and the year to date share price return is 9.56%, even as the 3 year total...

ACEA’s equity raise and dividend affirmation ACEA (BIT:ACE) has filed a follow on equity offering of €195.5 million, with 8,500,000 new shares at €23. This move puts fresh capital and potential dilution on investors’ radar. See our latest analysis for ACEA. The follow on offer and confirmed €0.95 dividend arrive after a 14.62% 1 month share price return decline. However, ACEA’s 24.33% 1 year total shareholder return and very large 3 year total shareholder return indicate that longer term...

Robosense Technology (SEHK:2498) closed FY 2025 with fourth quarter revenue of C¥750.7 million and basic EPS of C¥0.24, while the trailing twelve months showed revenue of C¥1.9 billion and a basic EPS loss of C¥0.32. Over recent quarters, revenue has moved from C¥513.9 million in Q4 FY 2024 to C¥750.7 million in Q4 FY 2025, with quarterly EPS shifting from a loss of C¥0.30 to a profit of C¥0.24. For investors, the mix of higher quarterly revenue, a swing to quarterly profitability, and an...

Fresenius Medical Care (XTRA:FME) is back in focus after a recent share move, with the stock closing at €38.40 and showing mixed returns over the past week, month, and past 3 months. See our latest analysis for Fresenius Medical Care. That latest move to €38.40 comes after a 7.22% 1 month share price decline and a 4.41% year to date share price pullback. The 1 year total shareholder return of a 12.80% decline contrasts with a 3 year total shareholder return of a 9.34% gain. If this kind of...

Genertec Universal Medical Group (SEHK:2666) has reported FY 2025 first half revenue of CNY 7.5b and basic EPS of CNY 0.65. Trailing twelve month EPS stands at CNY 1.13 and revenue at CNY 14.9b, helping frame the current earnings picture. The company’s revenue has moved from CNY 6.4b in 2024 H1 to CNY 6.9b in 2024 H2 and then to CNY 7.5b in 2025 H1. Net income excluding extra items tracked from CNY 1,137.2m to CNY 894.5m and then CNY 1,228.1m, setting up a results season where investors are...

Earlier in March 2026, Remitly Global director Joshua Hug sold just under 29,100 shares under a pre-arranged Rule 10b5-1 plan, a move that represented less than 1% of his direct holdings and appeared consistent with his historical trading behavior. At the same time, easing geopolitical tensions in the Middle East reduced market anxiety and supported a broad rally that benefited Remitly and other financial technology firms by improving sentiment toward cross-border financial activity. We’ll...

M. Scott Welch’s recent open market purchases of Lakeland Financial (LKFN) over a two week stretch, the first meaningful insider ownership increase since March 2025, have put fresh attention on the bank’s valuation during ongoing sector headwinds. See our latest analysis for Lakeland Financial. At a share price of $56.80, Lakeland Financial has moved sideways overall, with a 0.60% year-to-date share price return and a 1-year total shareholder return decline of 3.65%. The recent 7-day share...

Primoris Services (NYSE:PRIM) has been selected as the engineering, procurement and construction contractor for Arevon Energy's Cormorant Energy Storage Project in California. The contract covers a major utility scale battery energy storage facility that is intended to support grid reliability in the state. This award reflects Primoris's growing presence in large renewable and energy storage projects and is described as material for the company. Primoris Services, known for its...

In February 2026, Henry Schein reported strong fiscal 2025 fourth-quarter results, with total net sales rising 7.7% year over year and Global Specialty Products sales increasing 14.6%. This outperformance in higher-margin specialty products highlights the growing importance of these offerings within Henry Schein’s broader healthcare distribution and solutions portfolio. We’ll now examine how this strong specialty products growth shapes Henry Schein’s investment narrative and its focus on...

Earlier in March 2026, analysts at Craig-Hallum and BTIG reiterated positive views on GeneDx Holdings after data presented at the ACMG Annual Meeting indicated the company’s whole exome and genome tests can reduce healthcare resource use and overall costs. This combination of clinical utility data and analyst confidence highlights how GeneDx’s testing could appeal to payers focused on cost-effective care, especially in commercial and Medicaid channels. Next, we’ll examine how these...

Earlier this month, NVIDIA and Eaton announced the Eaton Beam Rubin DSX platform, integrating Eaton’s grid-to-chip power and cooling infrastructure with NVIDIA’s Vera Rubin DSX AI Factory reference design and Omniverse DSX blueprints to accelerate AI factory deployment. A particularly important aspect is Eaton’s use of digital twins and SimReady 3D assets, allowing customers to simulate power and cooling systems before construction for faster, more reliable AI data center rollouts. Now we’ll...

Wondering if Home BancShares at around US$26.62 is offering good value right now, or if the easy money has already been made. The stock is up 2.3% over the past week, although it shows a 5.9% loss over 30 days and a 4.6% loss year to date, with longer term returns of 31.2% over 3 years and 13.3% over 5 years, giving a mixed picture for investors. Recent coverage around Home BancShares has focused on how the bank is positioned within the wider US banking sector and how investors are...

Context for UMH Properties after recent share performance UMH Properties (UMH) has drawn fresh attention after recent trading, with the share price at $14.34 and showing negative returns over the past month and past 3 months. This has prompted investors to reassess the manufactured home REIT. See our latest analysis for UMH Properties. Recent trading tells a mixed story, with a 1 day share price return of 0.56%, a 30 day share price return showing an 11.48% decline, and a 1 year total...

What recent moves in uniQure (QURE) might be telling you Recent trading in uniQure (QURE) has been choppy, with the stock up about 7% over the past week but showing declines over the past month and past 3 months, which puts current sentiment in sharper focus. See our latest analysis for uniQure. At a share price of US$16.36, uniQure’s recent 7 day share price return of 7.21% sits alongside a 30 day share price return of 31.92% and a year to date share price return of 30.06%. The 1 year total...

Tuas Limited recently reported half-year results to January 31, 2026, with sales of S$91.91 million and net income of S$8.23 million, both higher than the same period a year earlier. The jump in basic earnings per share from S$0.0065 to S$0.0153 highlights how improved profitability is flowing through to shareholders. We will now examine how Tuas’s stronger earnings and improved profitability shape its broader investment narrative for investors. The best AI stocks today may lie beyond giants...

China Resources Pharmaceutical Group (SEHK:3320) FY 2025 Earnings Snapshot China Resources Pharmaceutical Group (SEHK:3320) has posted its latest FY 2025 numbers with first half revenue of about C¥131.9b and basic EPS of C¥0.33, set against trailing twelve month EPS of C¥0.64. The company has seen revenue move from roughly C¥128.6b in 1H 2024 to C¥131.9b in 1H 2025, while basic EPS shifted from C¥0.41 in 1H 2024 and C¥0.12 in 2H 2024 to C¥0.33 in the latest half. This sets up a discussion...

Dividend and earnings event Iren (BIT:IRE) has drawn fresh attention after reporting full year 2025 results alongside an annual dividend announcement, giving investors new information on both the company’s profitability and its planned cash return to shareholders. The utility group reported 2025 sales of €6,333.39 million and revenue of €6,574.06 million, with net income of €300.55 million compared with €268.47 million a year earlier, and set an annual dividend of €0.1386 per share. See our...

VAALCO Energy (EGY) is on investors’ radar after releasing fourth quarter and full year 2025 results that showed a shift to a net loss, lower production volumes, and fresh 2026 production guidance. See our latest analysis for VAALCO Energy. The earnings miss and 2026 production guidance have arrived against a backdrop of strong momentum, with a 30 day share price return of 22.42% and a 1 year total shareholder return of 71.16%. This suggests sentiment has strengthened recently despite weaker...

In March 2026, Netflix announced an exclusive multi-year first-look deal with Warner Music Group to create documentary series and films featuring WMG artists and songwriters, with Unigram acting as the production arm for long-form programming developed alongside artists or their estates. This partnership gives Warner Music Group a new route to spotlight its extensive artist roster on a global streaming platform, potentially deepening fan engagement and enhancing the long-term value of its...

Dongyue Group (SEHK:189) has posted fresh FY 2025 numbers, with first half revenue of C¥7.5b, basic EPS of C¥0.47 and trailing 12 month EPS of C¥0.98 helping frame a sharp earnings rebound over the past year. The company has seen revenue move from C¥7.3b in the first half of FY 2024 to C¥7.5b in the first half of FY 2025, while net income excluding extra items shifted from C¥307.6m to C¥779.2m. This sets up investors to focus on how far the recent 102.5% trailing earnings growth and 11.4% net...

Investors may be wondering whether Miami International Holdings at around US$38.51 is offering fair value right now, or if the price is out of step with the business. The stock has been relatively soft recently, with a 2.6% decline over the last 7 days, a 1.2% decline over 30 days, and an 11.8% decline year to date. Recent coverage around Miami International Holdings has focused on providing ongoing context for the stock, giving investors a clearer view of how the business is being assessed...

Sonoco Products (SON) is back on investor radar after recent share price swings, with the stock showing mixed short term moves alongside contrasting one month and past three month returns. See our latest analysis for Sonoco Products. The recent share price swings also sit against a stronger backdrop, with a 23.77% 90 day share price return and 20.40% year to date share price return pointing to building momentum despite a weaker 30 day patch and more muted multi year total shareholder...

Intro InnoCare Pharma (SEHK:9969) just closed FY 2025 with fourth quarter revenue of C¥1.3b and net income of C¥706.9m, a sharp step up from the smaller quarterly figures that characterised most of the year. The company has seen quarterly revenue move from C¥311.7m in Q4 2024 to C¥381.3m in Q1 2025, C¥350.2m in Q2, C¥383.9m in Q3 and finally C¥1.3b in Q4, while basic EPS across the year swung between a gain of C¥0.01 in Q1 and losses of C¥0.0396 and C¥0.0188 in Q2 and Q3. This sets up a...